|
Volumn 678, Issue 1, 1996, Pages 63-72
|
Simultaneous determination of nerisopam, a novel anxiolytic agent showing polymorphic metabolism, and its N-acetyl metabolite from human plasma by a validated high-performance liquid chromatographic method
a a a b c |
Author keywords
N Acetylnerisopam; Nerisopam
|
Indexed keywords
DRUG METABOLITE;
EGIS 7649;
NERISOPAM;
UNCLASSIFIED DRUG;
ACCURACY;
ACETYLATION;
ACETYLATOR PHENOTYPE;
ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG METABOLISM;
GENETIC POLYMORPHISM;
HUMAN;
HUMAN EXPERIMENT;
HUMAN TISSUE;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SOLID PHASE EXTRACTION;
TECHNIQUE;
ULTRAVIOLET SPECTROPHOTOMETRY;
ANTI-ANXIETY AGENTS;
BENZODIAZEPINES;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SPECTROPHOTOMETRY, ULTRAVIOLET;
|
EID: 0029868290
PISSN: 15726495
EISSN: None
Source Type: Journal
DOI: 10.1016/0378-4347(95)00289-8 Document Type: Article |
Times cited : (10)
|
References (6)
|